SlideShare una empresa de Scribd logo
1 de 23
Transforming Bulgarian  Acute Coronary Syndrome Strategy in 2 years Bulgarian Cardiac Institute Slaveyko Djambazov, MD Chief Executive Officer E: s.djambazov.hq@comleague.com Sinaia,  September, 2009
Bulgaria ,[object Object],[object Object],[object Object],500 km
Regional Variations in CV Mortality S.Djambazov, P.Widimsky et al.  (pending World Cardiology Congress, China 2010) 1,42% 1,17% 0,94% 0,96% 0,90% 0,95% The relative risk of cardiovascular death is 27% higher in regions without tertiary cardiac care facilities when compared with regions having  those
Trends in Cardiovascular Mortality source: NHIF 2007 *assumptions based on Czech registry Result: Extremely high absolute in-hospital ACS mortality – app. 15% source: NHIF, MoH, NSI 2007 168 TL/1mln 132 pPCI/1mln 700 STEMI/1mln* 3250 ACS/1mln*
Reasons ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Project ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
UniCardio Clinic Pleven First STEMI pt The rest of Brno team followed that policy and it became main focus of the Bulgarian Cardiac Institute
Ferrari Widimsky Mauri Pezzano Grigorov Pleven Veliko Tarnovo BCI works closely with ESC
Procedures-Pleven-Oct 07-June 09 2008 2009 VT JM open Extension
Improvement of primary and secondary transportation –  compensating the insufficient state system Fleet of 18 own ambulances for primary and secondary transportation Equipment for transportation of patients in cardiogenic shock, IABP, ventilation
BCI ambulances strategic positioning: 24/7 Coverage of app.80% of the territory and 65% of the population Next step: real-time ECG transfer via GSM network from  ALL  hospitals to BCI ambulances and BCI centers
Scientific Activities ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],With Professor JP Bassand on board and intensive collaboration with Ludwighafen clinic (Germany) BCI established own research network - €1 mln/ year
Overall capacity of BCI 5 500 1 121 PCIs 1 300 296 pPCIs 45 14 Cardiologists 5 (36) 1 (4) International teams 23 3 Trainees in interventional cardiology 32 8 CCU beds 178 adj. 56 Cardiac hospital beds 21 000 6 377 Invasive procedures 140 000 60 000 Patients examned est. 2009 2008
Procedures-BCI-Oct `07-May `09 2008 2009 VT JM VN For that period more than 550(!) lectures were delivered across the country – own  private  budget
Further expansion 2009 - 2011 ,[object Object],[object Object],[object Object],Est.   60% 35% 33%
Further Expansion in place
International Cooperation
Difficulties ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Overcoming difficulties Till 09.2007- STEMI- 585 1st year of work- STEMI- 764 ACS in-hospital mortality rate reduction in Pleven for 1 year- 30% Unrivalled network capacity and ACS treatment organization   Source: T . Vekov ,  M . Grigorov ,  O.Hlinomaz, L.Groch, J.Sitar, M.Rezek, S . Djambazov ,  B.Kuzmanov, V.Hristov, Journal of Biomedical and Clinical Research ,  volume  1,  number  1;  Any secrets? call centres BCI gets same reimbursement as state hospitals
Stent for life Percentage of STEMI patients not treated by reperfusion (neither p-PCI, nor thrombolysis).   Mean in-hospital mortality of all STEMI patients (including those not treated by reperfusion) in countries with p-PCI dominance and thrombolysis dominance   Source: P.Widimsky et al; Reperfusion therapy for ST-elevation acute myocardial infarction in Europe (not published data)
Stent for life Bulgaria ,[object Object],[object Object],[object Object],[object Object]
Considerations: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Healthcare is never immune to saturation Our goal is to achieve 400 pPCI per 1 mln in 3 years Is BCI for profit organization? Thank you! and also to all my colleagues and friends from Czech Republic and BCI family of hospitals

Más contenido relacionado

Destacado

UC EXPO 2010 - The unified communications journey from ideas to deployment at...
UC EXPO 2010 - The unified communications journey from ideas to deployment at...UC EXPO 2010 - The unified communications journey from ideas to deployment at...
UC EXPO 2010 - The unified communications journey from ideas to deployment at...guest7ed636d1
 
Operating System - Ch5
Operating System - Ch5Operating System - Ch5
Operating System - Ch5Resty Aldana
 
Transformation of Acute Cardiac Care in BG April 2010
Transformation of Acute Cardiac Care in BG April 2010Transformation of Acute Cardiac Care in BG April 2010
Transformation of Acute Cardiac Care in BG April 2010Medical University Sofia
 
Paola Visentin, my story
Paola Visentin, my storyPaola Visentin, my story
Paola Visentin, my storyPaola Visentin
 
Trace id fashion conference 2010 softwork
Trace id fashion conference 2010 softworkTrace id fashion conference 2010 softwork
Trace id fashion conference 2010 softworkPaola Visentin
 
BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...
BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...
BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...guest7ed636d1
 
Wk6 more onstoryboarding
Wk6 more onstoryboardingWk6 more onstoryboarding
Wk6 more onstoryboardingResty Aldana
 
Press Release 2010 Softwork
Press Release 2010 Softwork Press Release 2010 Softwork
Press Release 2010 Softwork Paola Visentin
 
RFID & NFC a Smart Mobility World 2014
RFID & NFC a Smart Mobility World 2014RFID & NFC a Smart Mobility World 2014
RFID & NFC a Smart Mobility World 2014Paola Visentin
 
RFID Value Chain di Softwork a TraceID Fashion 2011
RFID Value Chain di Softwork a TraceID Fashion 2011RFID Value Chain di Softwork a TraceID Fashion 2011
RFID Value Chain di Softwork a TraceID Fashion 2011Paola Visentin
 
SMAU Milano 2013: work shop RFID Global by Softwork
SMAU Milano 2013: work shop RFID Global by SoftworkSMAU Milano 2013: work shop RFID Global by Softwork
SMAU Milano 2013: work shop RFID Global by SoftworkPaola Visentin
 
SMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventional
SMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventionalSMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventional
SMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventionalPaola Visentin
 
RFID nella tracciabilità sanitaria
RFID nella tracciabilità sanitariaRFID nella tracciabilità sanitaria
RFID nella tracciabilità sanitariaPaola Visentin
 
Tecnologia RFID per tracciare i prodotti ed innovare i servizi
Tecnologia RFID per tracciare i prodotti ed innovare i serviziTecnologia RFID per tracciare i prodotti ed innovare i servizi
Tecnologia RFID per tracciare i prodotti ed innovare i serviziPaola Visentin
 
NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...
NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...
NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...Paola Visentin
 
RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015
RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015
RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015Paola Visentin
 

Destacado (17)

UC EXPO 2010 - The unified communications journey from ideas to deployment at...
UC EXPO 2010 - The unified communications journey from ideas to deployment at...UC EXPO 2010 - The unified communications journey from ideas to deployment at...
UC EXPO 2010 - The unified communications journey from ideas to deployment at...
 
Operating System - Ch5
Operating System - Ch5Operating System - Ch5
Operating System - Ch5
 
NutriLive Care Feb 2015
NutriLive Care Feb 2015NutriLive Care Feb 2015
NutriLive Care Feb 2015
 
Transformation of Acute Cardiac Care in BG April 2010
Transformation of Acute Cardiac Care in BG April 2010Transformation of Acute Cardiac Care in BG April 2010
Transformation of Acute Cardiac Care in BG April 2010
 
Paola Visentin, my story
Paola Visentin, my storyPaola Visentin, my story
Paola Visentin, my story
 
Trace id fashion conference 2010 softwork
Trace id fashion conference 2010 softworkTrace id fashion conference 2010 softwork
Trace id fashion conference 2010 softwork
 
BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...
BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...
BT Conferencing,"UC expo","UC expo 2010","Flexible Working","Thursday 11th Ma...
 
Wk6 more onstoryboarding
Wk6 more onstoryboardingWk6 more onstoryboarding
Wk6 more onstoryboarding
 
Press Release 2010 Softwork
Press Release 2010 Softwork Press Release 2010 Softwork
Press Release 2010 Softwork
 
RFID & NFC a Smart Mobility World 2014
RFID & NFC a Smart Mobility World 2014RFID & NFC a Smart Mobility World 2014
RFID & NFC a Smart Mobility World 2014
 
RFID Value Chain di Softwork a TraceID Fashion 2011
RFID Value Chain di Softwork a TraceID Fashion 2011RFID Value Chain di Softwork a TraceID Fashion 2011
RFID Value Chain di Softwork a TraceID Fashion 2011
 
SMAU Milano 2013: work shop RFID Global by Softwork
SMAU Milano 2013: work shop RFID Global by SoftworkSMAU Milano 2013: work shop RFID Global by Softwork
SMAU Milano 2013: work shop RFID Global by Softwork
 
SMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventional
SMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventionalSMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventional
SMAU Milano 2015: RFID, NFC & Bluetooth Smart unconventional
 
RFID nella tracciabilità sanitaria
RFID nella tracciabilità sanitariaRFID nella tracciabilità sanitaria
RFID nella tracciabilità sanitaria
 
Tecnologia RFID per tracciare i prodotti ed innovare i servizi
Tecnologia RFID per tracciare i prodotti ed innovare i serviziTecnologia RFID per tracciare i prodotti ed innovare i servizi
Tecnologia RFID per tracciare i prodotti ed innovare i servizi
 
NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...
NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...
NARRABILITY 2014 - Concept del IV Convegno Nazionale Storytelling by Osservat...
 
RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015
RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015
RFID Global, Conferenza IoX - Internet of People & Things, M2M & IoT Forum 2015
 

Similar a Transforming BG ACS strategy (version Sinaia)

Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...
Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...
Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...Chaichuk Sergiy
 
14 mentality and organisational changes are key to developing primary angiopl...
14 mentality and organisational changes are key to developing primary angiopl...14 mentality and organisational changes are key to developing primary angiopl...
14 mentality and organisational changes are key to developing primary angiopl...NPSAIC
 
The effective national primary angioplasty network. Petr Widimský
The effective national primary angioplasty network. Petr WidimskýThe effective national primary angioplasty network. Petr Widimský
The effective national primary angioplasty network. Petr WidimskýChaichuk Sergiy
 
Effect eng
Effect engEffect eng
Effect engNPSAIC
 
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...Investnet
 
Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...
Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...
Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...Chaichuk Sergiy
 
The principles of the initiative „Stent for Life” in Poland: advantages and d...
The principles of the initiative „Stent for Life” in Poland: advantages and d...The principles of the initiative „Stent for Life” in Poland: advantages and d...
The principles of the initiative „Stent for Life” in Poland: advantages and d...Chaichuk Sergiy
 
publishedpaper2011
publishedpaper2011publishedpaper2011
publishedpaper2011John Cooper
 
19 stent for life initiative – the greek experience
19 stent for life initiative – the greek experience19 stent for life initiative – the greek experience
19 stent for life initiative – the greek experienceNPSAIC
 
23 stent for life project present situation in turkey
23 stent for life project present situation in turkey23 stent for life project present situation in turkey
23 stent for life project present situation in turkeyNPSAIC
 
Sergey Boytsov, State Scientific Research Institute of Organization and Infor...
Sergey Boytsov, State Scientific Research Institute of Organization and Infor...Sergey Boytsov, State Scientific Research Institute of Organization and Infor...
Sergey Boytsov, State Scientific Research Institute of Organization and Infor...Sosiaali- ja terveysministeriö / yleiset
 
16 decreasing stemi mortality by implementing a ppci network in bulgaria
16 decreasing stemi mortality by implementing a ppci network in bulgaria16 decreasing stemi mortality by implementing a ppci network in bulgaria
16 decreasing stemi mortality by implementing a ppci network in bulgariaNPSAIC
 
eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...
eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...
eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...NugrahaPranadipta
 
What do we need to indicate CTO PCI?
What do we need to indicate CTO PCI?What do we need to indicate CTO PCI?
What do we need to indicate CTO PCI?Euro CTO Club
 
20 issue article-21
20 issue article-2120 issue article-21
20 issue article-21NPSAIC
 
21 primary angioplasty in portugal door to-balloon time is not a good perform...
21 primary angioplasty in portugal door to-balloon time is not a good perform...21 primary angioplasty in portugal door to-balloon time is not a good perform...
21 primary angioplasty in portugal door to-balloon time is not a good perform...NPSAIC
 

Similar a Transforming BG ACS strategy (version Sinaia) (20)

Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...
Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...
Структура «Реперфузионной Сети» Чешской Республики. Первичное стентирование д...
 
14 mentality and organisational changes are key to developing primary angiopl...
14 mentality and organisational changes are key to developing primary angiopl...14 mentality and organisational changes are key to developing primary angiopl...
14 mentality and organisational changes are key to developing primary angiopl...
 
The effective national primary angioplasty network. Petr Widimský
The effective national primary angioplasty network. Petr WidimskýThe effective national primary angioplasty network. Petr Widimský
The effective national primary angioplasty network. Petr Widimský
 
Effect eng
Effect engEffect eng
Effect eng
 
13 FFR Berry C aimradial2016 - FFR in non-STEMI
13 FFR Berry C aimradial2016 - FFR in non-STEMI13 FFR Berry C aimradial2016 - FFR in non-STEMI
13 FFR Berry C aimradial2016 - FFR in non-STEMI
 
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
 
Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...
Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...
Recommendation for stemi treatment in 2013 and stent for life initiative.Petr...
 
The principles of the initiative „Stent for Life” in Poland: advantages and d...
The principles of the initiative „Stent for Life” in Poland: advantages and d...The principles of the initiative „Stent for Life” in Poland: advantages and d...
The principles of the initiative „Stent for Life” in Poland: advantages and d...
 
HAI-Net ICU results and perspectives. Carl Suetens (ECDC)
HAI-Net ICU results and perspectives. Carl Suetens (ECDC)HAI-Net ICU results and perspectives. Carl Suetens (ECDC)
HAI-Net ICU results and perspectives. Carl Suetens (ECDC)
 
publishedpaper2011
publishedpaper2011publishedpaper2011
publishedpaper2011
 
04 aimradial2016 fri T Tokarek/Z Siudak
04 aimradial2016 fri T Tokarek/Z Siudak04 aimradial2016 fri T Tokarek/Z Siudak
04 aimradial2016 fri T Tokarek/Z Siudak
 
19 stent for life initiative – the greek experience
19 stent for life initiative – the greek experience19 stent for life initiative – the greek experience
19 stent for life initiative – the greek experience
 
23 stent for life project present situation in turkey
23 stent for life project present situation in turkey23 stent for life project present situation in turkey
23 stent for life project present situation in turkey
 
Sergey Boytsov, State Scientific Research Institute of Organization and Infor...
Sergey Boytsov, State Scientific Research Institute of Organization and Infor...Sergey Boytsov, State Scientific Research Institute of Organization and Infor...
Sergey Boytsov, State Scientific Research Institute of Organization and Infor...
 
16 decreasing stemi mortality by implementing a ppci network in bulgaria
16 decreasing stemi mortality by implementing a ppci network in bulgaria16 decreasing stemi mortality by implementing a ppci network in bulgaria
16 decreasing stemi mortality by implementing a ppci network in bulgaria
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...
eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...
eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020commi...
 
What do we need to indicate CTO PCI?
What do we need to indicate CTO PCI?What do we need to indicate CTO PCI?
What do we need to indicate CTO PCI?
 
20 issue article-21
20 issue article-2120 issue article-21
20 issue article-21
 
21 primary angioplasty in portugal door to-balloon time is not a good perform...
21 primary angioplasty in portugal door to-balloon time is not a good perform...21 primary angioplasty in portugal door to-balloon time is not a good perform...
21 primary angioplasty in portugal door to-balloon time is not a good perform...
 

Último

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 

Último (20)

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 

Transforming BG ACS strategy (version Sinaia)

  • 1. Transforming Bulgarian Acute Coronary Syndrome Strategy in 2 years Bulgarian Cardiac Institute Slaveyko Djambazov, MD Chief Executive Officer E: s.djambazov.hq@comleague.com Sinaia, September, 2009
  • 2.
  • 3. Regional Variations in CV Mortality S.Djambazov, P.Widimsky et al. (pending World Cardiology Congress, China 2010) 1,42% 1,17% 0,94% 0,96% 0,90% 0,95% The relative risk of cardiovascular death is 27% higher in regions without tertiary cardiac care facilities when compared with regions having those
  • 4. Trends in Cardiovascular Mortality source: NHIF 2007 *assumptions based on Czech registry Result: Extremely high absolute in-hospital ACS mortality – app. 15% source: NHIF, MoH, NSI 2007 168 TL/1mln 132 pPCI/1mln 700 STEMI/1mln* 3250 ACS/1mln*
  • 5.
  • 6.
  • 7. UniCardio Clinic Pleven First STEMI pt The rest of Brno team followed that policy and it became main focus of the Bulgarian Cardiac Institute
  • 8. Ferrari Widimsky Mauri Pezzano Grigorov Pleven Veliko Tarnovo BCI works closely with ESC
  • 9. Procedures-Pleven-Oct 07-June 09 2008 2009 VT JM open Extension
  • 10. Improvement of primary and secondary transportation – compensating the insufficient state system Fleet of 18 own ambulances for primary and secondary transportation Equipment for transportation of patients in cardiogenic shock, IABP, ventilation
  • 11. BCI ambulances strategic positioning: 24/7 Coverage of app.80% of the territory and 65% of the population Next step: real-time ECG transfer via GSM network from ALL hospitals to BCI ambulances and BCI centers
  • 12.
  • 13. Overall capacity of BCI 5 500 1 121 PCIs 1 300 296 pPCIs 45 14 Cardiologists 5 (36) 1 (4) International teams 23 3 Trainees in interventional cardiology 32 8 CCU beds 178 adj. 56 Cardiac hospital beds 21 000 6 377 Invasive procedures 140 000 60 000 Patients examned est. 2009 2008
  • 14. Procedures-BCI-Oct `07-May `09 2008 2009 VT JM VN For that period more than 550(!) lectures were delivered across the country – own private budget
  • 15.
  • 18.
  • 19. Overcoming difficulties Till 09.2007- STEMI- 585 1st year of work- STEMI- 764 ACS in-hospital mortality rate reduction in Pleven for 1 year- 30% Unrivalled network capacity and ACS treatment organization Source: T . Vekov , M . Grigorov , O.Hlinomaz, L.Groch, J.Sitar, M.Rezek, S . Djambazov , B.Kuzmanov, V.Hristov, Journal of Biomedical and Clinical Research , volume 1, number 1; Any secrets? call centres BCI gets same reimbursement as state hospitals
  • 20. Stent for life Percentage of STEMI patients not treated by reperfusion (neither p-PCI, nor thrombolysis). Mean in-hospital mortality of all STEMI patients (including those not treated by reperfusion) in countries with p-PCI dominance and thrombolysis dominance Source: P.Widimsky et al; Reperfusion therapy for ST-elevation acute myocardial infarction in Europe (not published data)
  • 21.
  • 22.
  • 23. Healthcare is never immune to saturation Our goal is to achieve 400 pPCI per 1 mln in 3 years Is BCI for profit organization? Thank you! and also to all my colleagues and friends from Czech Republic and BCI family of hospitals